Demyelinating disease associated with use of etanercept in patients with seronegative spondyloarthropathies

Journal of Rheumatology

Volumn 35, Issue 7, 2008, Pages 1469-1471

  Davis, Stacy A ^a   Johnson, Robert R ^a,b,c   Pendleton, John W ^a,d  

^a Carilion Clinic

^b UNIVERSITY OF VIRGINIA   (United States)

^c EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BETA INTERFERON; ETANERCEPT; METHOTREXATE;

ADULT; ANKYLOSING SPONDYLITIS; BACKACHE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATING DISEASE; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; LEG CRAMP; LETTER; MALE; PARESTHESIA; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVITIS; URINE INCONTINENCE; VISUAL DISORDER;

ADULT; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLARTHROPATHIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47349113688     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Sukal SA, Nadiminti L, Granstein RD. Etanercept and demyelinating disease in a patient with psoriasis. J Am Acad Dermatol 2006;54:160-4.
2. Mease PJ, Kivitz AJ, Burch FX, et al. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. J Rheumatol 2006;33:712-21.
3. Amgen Medical Information Department; data on file, Feb 2007,V5.0.
4. Hyrich KL, Silman AJ, Watson KD, Symmons DPM. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 2004;63:1538-43.
5. Weisman MH. What are the risks of biologic therapy in rheumatoid arthritis? An update on safety. J Rheumatol 2002;29 Suppl 65:33-8.
6. Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001;44:2862-9.
7. Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 2001;57:1885-8.
8. Al Saieg N, Luzar MJ. Etanercept induced multiple sclerosis and transverse myelitis. J Rheumatol 2006;33:1202-4.
9. Hyrich KL, Silman AJ, Watson KD, et al. Anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 2004;63:1538-43.